Corcept loses patent fight with Teva over Cushing's syndrome drug
Corcept Therapeutics lost its patent infringement lawsuit against Teva Pharmaceuticals over its Cushing’s syndrome drug Korlym after a New Jersey judge …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
